Cancer drug resistance is a complex phenomenon that is influenced by drug inactivation, drug target. Members are elected by their peers for outstanding contributions to research. The increase in the understanding of the molecular and biochemical bases of drug efficacy has also facilitated studies elucidating the mechanisms of drug resistance. In this study, we proposed a dynamic networkbased computational method to prioritize the key genes responsible for cancer drug resistance, which is significantly innovative compared to the. Experimental approaches that can help predict the eventual clinical drug resistance, coupled with the evolution of systematic genomic. All successful cancer therapies are limited by the development of drug resistance. Here, we discuss evidence for distinct modes of tumor evolution and their implications for therapeutic strategies. Specifically, comparisons of pre and posttreatment samples can reveal the underlying clonal dynamics and resistance mechanisms. The field of cellular therapy for myeloma is evolving rapidly, and a paradigm shift in treatment is on the horizon, according to adam d.
Similarly, tumor cells in regions of hypoxia may be protected as a result of increased expression. Also, some tumor cells may carry a gene that can develop resistance induced by the therapeutic drug. The national academy of engineering was established in 1964 under. As a control experiment, most of the premodified drugs the acr drugs and smccdox presented sabotaged efficacy. This progress is highlighted by the dramatic clinical responses seen with drugs. The mechanisms of resistance to classical cytotoxic chemotherapeutics and to therapies that are designed to be selective for specific molecular targets share many features, such as alterations in the drug target, activation of prosurvival pathways and ineffective induction of cell death. In many instances, drug resistance is correlated with aberrant metabolic adaptations that favor aerobic glycolysis over oxidative phosphorylation. From the second postwar to the advent of the new millennium, there has been an increase in the number of drugs and therapies available for the treatment of all hematological and solid tumors that have contributed to the significant reduction in cancer mortality rates. Moleculebased prediction of drug response is one major task of precision oncology. Recently, largescale cancer genomic studies, such as the cancer genome atlas tcga, provide the opportunity to evaluate the predictive utility of molecular data for clinical drug responses in multiple cancer types.
Platinumbased chemotherapy improves survival among patients with nonsmall cell lung cancer nsclc, but the efficiency is limited due to resistance. He develops and harnesses data science approaches for the integration of multiomics data to better understand the pathogenesis of cancer, its evolution and treatment. In drug resistant breast cancer cells, high expression of. To establish a highquality database of ncrnas, all the. It is a challenge to identify of clinically meaningful tools for outcome prediction. Caitriona holohan, sandra van schaeybroeck, daniel b. In this study, we developed a prognosis model fused clinical characteristics with drug resistance pharmacogenomic signature to. Cancer drug resistancefrom laundry list to paradigms.
Resistance to chemotherapeutics can be divided into two broad categories. This makes the population of cancer cells in any tumor, or any other cancer cells that come from a distinct origin one parent cell highly variable. Resistance to anticancer drugs arises from a wide variety of factors, such as genetic. Cancer drug resistance remains a major cause of death of cancer patients. Center of excellence for evolutionary therapy moffitt. To model the mechanisms of intrinsic and acquired resistance to anticancer drugs 5, we need distinct experimental designs. The differentiation hierarchy model of cancer is dependent on the gain and loss of the various markers used to identify the. Circumventing cancer drug resistance in the era of. Cancer is a product of evolution, and understanding how cancer evolves may be a key to more successful treatment strategies. Antitumor drug resistance remains a major challenge in cancer chemotherapy. Cancer drug resistance is an open access journal, focusing on pharmacological aspects of drug resistance and its reversal, molecular mechanisms of drug resistance and drug classes, etc. Cohen, md, director of myeloma immunotherapy at the abramson cancer center, philadelphia, pennsylvania.
In some cases, there are already drug resistant cancer cells at. Holohan and others published longley db and johnston pg. We propose that drug ineffectiveness results from tumorhost interactions and that a clear understanding of such an interaction open new opportunities not only for the discovery of new drugs but also for new therapeutic strategies to overcome the development and evolution of resistance to cancer. A canonical example is the upregulation of abcb1 also known as multi drug resistance protein 1 mdr1, an efflux protein involved in removing foreign substances including drugs from cells. In this study, we aimed to identify the expression of auroraa and its correlation with cisplatin resistance and prognosis in nsclc. Correlation of long noncoding rna expression with metastasis, drug resistance and clinical outcome in cancer. Resistance to chemotherapy and molecularly targeted therapies is a major problem facing current cancer research. Theres no reason why we cant stay one step ahead of cancer and ensure that it becomes a manageable disease in future.
For example, in environmentally mediated drug resistance emdr, components of tumor mesenchyma protect cancer cells from what would otherwise be lethal concentrations of cytotoxic drugs meads et al. New faculty center for cancer research national cancer. Evaluating the moleculebased prediction of clinical drug. Previous studies have shown that a common mechanism of drug resistance in various tumors is overexpression of a drug efflux pump such as pgp. Drug resistance is a particularly pernicious feature of modern cancer chemotherapy. Nih funding opportunities and notices in the nih guide for grants and contracts. Major physiological signaling pathways in the regulation of cell proliferation and survival. Mechanisms of cancer drug resistance and sensitivity u54 rfaca17009. In contrast to conventional chemotherapy, which acts on all dividing cells. Anderson performed his doctoral work on hybrid mathematical models of nematode movement in heterogeneous environments at the scottish crop research institute in dundee, uk.
Highthroughput sequencing can be used to measure changes in tumor composition across space and time. Molecular and pharmacological mechanisms of drug resistance. Auroraa contributes to cisplatin resistance and lymphatic. While it is widely held that the phenomenon is genetic in nature, emerging evidence suggests that nongenetic mechanisms may also be important. For intrinsic resistance mechanisms, the gene expression or. Similarly, tumor cells in regions of hypoxia may be protected as a result of increased expression of pgp, upregulation survival pathways, increased mutagenesis, and decreased drug delivery. To establish a highquality database of ncrnas, all the articles related to drug resistance and ncrnas were manually extracted from publications fig. An integrated prognosis model of pharmacogenomic gene. These are mechanisms that cause cancer cells to develop resistance to many drugs. Harnessing tumor evolution to circumvent resistance. Benedetta colmegna, lavinia morosi, maurizio dincalci. It is particularly important to prioritise and accelerate drugs acting on novel targets and with novel mechanisms of action, because it is combinations of such mechanistically innovative agents that are most likely to have an impact on overcoming cancer evolution and drug resistance, the major clinical problem we currently face in cancer treatment. Targeted therapies in cancer and mechanisms of resistance. Both clinical and experimental aspects of drug resistance in cancer are included.
Furthermore, at least in some cases, refractoriness to treatment can be reversed by epigenetic reprogramming, and combination. An evolving paradigm resistance to chemotherapy and molecularly targeted therapies is a major. Understanding, predicting cancer evolution may open door to clinical research options. Research has shown that cancer cells can use any number of genes and strategies to achieve or acquire resistance to cancer drug resistance from laundry list to paradigms broad institute. Bacteriaantibiotic resistance endoparasites viruses resistance to antiviral drugs fungi cancer cells 8.
Sandy anderson is the center of excellence for evolutionary therapy director and serves as chair of integrated mathematical oncology imo. Such data from many patients with diverse cancer types can inform the treatment decisions of other patients with similar mutations. Eribulin is a potential substrate of pgp, and some cell lines, including a breast cancer cell line, have acquired resistance to eribulin via overexpression of mdr1 and pgp. Transfer learning tl algorithms aim to improve the prediction performance in a target task e. Evolving paradigms in the management of multiple myeloma. Rare cancers ther evolving paradigms in the management of multiple myeloma. Among new generations of tumor cells, some may express intrinsic resistance to a specific chemotherapeutic agent. Caitriona holohan caitriona holohan is a postdoctoral research fellow in the centre for cancer research and cell biology at queens university belfast, uk, where her research is focused on cell death signalling in cancer. Evolution of cancer can shed light on drug resistance. Antibiotic resistance the concentration of drug at the site ofinfection must inhibit the organism and alsoremain below the level that is toxic to humancells. The national academy of sciences was established in 1863 by an act of congress, signed by president lincoln, as a private, nongovernmental institution to advise the nation on issues related to science and technology. Drug resistance and combating drug resistance in cancer.
Cancer drug resistance leading to therapeutic failure in the treatment of many cancers encompasses various mechanisms and may be intrinsic relying on the patients genetic makeup or be acquired by tumors that are initially sensitive to cancer drugs. Big data approaches for modeling response and resistance. Exploiting evolutionary herding to control drug resistance in cancer. Intrinsic resistance indicates that before receiv ing chemotherapy, resistancemediating factors preexist in the bulk of tumour cells that make the therapy ineffective. Frontiers evolution of cancer pharmacological treatments. An evolving paradigm of cancer stem cell hierarchies. Author summary leveraging global gene expression patterns to study dynamical mechanisms of cancer drug resistance is an appealing yet challenging task for both experimental and computational biologists. With continued support, and by bringing cancer evolution experts together with our drug discovery colleagues in the new building, i believe we can help usher in a new era in cancer treatment. However, the mechanisms involved remain poorly understood.
Cancer cell lines for drug discovery and development. Mechanisms of drug resistance in cancer therapy mario mandala. The acquisition of drug resistance accounts for the majority of therapy failure of chemotherapy in gc patients. Author summary here, we provide mathematical and empirical evidence to support a potentially new paradigm in drug resistance, which we have termed cooperative adaptation to therapy cat.
The synthetic ease, cancer selectivity, and effectiveness of this approach, coupled with the lack of appreciable wholeanimal toxicity during treatment, make this strategy one that could have broad appeal as a paradigm for overcoming drug resistance. The geneticnongenetic duality of drug resistance in cancer. Cat is defined by a phenomenon wherein drug sensitive cancer cells with different genetic and phenotypic features within a 3dimensional heterogeneous tumor induce nonmutational resistance in their. A transfer learning approach via procrustes analysis and. Differential regulatory networkbased quantification and. In conclusion, it is clear that cancer drug treatments are constantly evolving. Kumar division of hematology, department of medicine, mayo clinic, rochester, mn, usa multiple myeloma mm is a clonal plasma cell disorder defined by bone marrow infiltration and osteolytic bone lesions and is the second most. An evolving paradigm resistance to chemotherapy and molecularly targeted therapies is a major problem facing current cancer research. In situinduced multivalent anticancer drug clusters in. All of the analyses performed by geco generate downloadable cvs files, for the tables, and highresolution pdf files, for the graph outputs, simplifying the data storage, analysis and publication.
Drug induced resistance is one the major obstacles that may lead to therapeutic failure during cancer treatment. Multi drug resistance mdr is commonly observed in clinical oncology. What really matters response and resistance in cancer. Here we investigated the mechanism of acquired resistance to a novel anticancer agent rh1 designed to be activated in cancer cells by the nqo1 enzyme. Drug resistance is a serious impediment to the treatment of cancer. A better understanding of the diversity of ovarian cancers will. However, evolving resistance to one drug may come at a cost of decreased growth rate or. Cooperative adaptation to therapy cat confers resistance.
1189 342 104 494 1103 146 1287 421 1122 463 1379 646 540 175 206 1158 850 694 406 34 33 395 1030 381 764 1496 1117 1134 1487 745 222 1275 575